A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Engineered lentivector targeting of dendritic cells for in vivo immunizationNature Biotechnology, 2008
- In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse ModelsJournal of Immunotherapy, 2007
- In Vivo Targeting of DC-SIGN-positive Antigen-presenting Cells in a Nonhuman Primate ModelJournal of Immunotherapy, 2007
- Contrasting Effects of Human, Canine, and Hybrid Adenovirus Vectors on the Phenotypical and Functional Maturation of Human Dendritic Cells: Implications for Clinical EfficacyJournal of Virology, 2007
- Receptor-Mediated Delivery of Antigens to Dendritic Cells: Anticancer ApplicationsMolecular Pharmaceutics, 2007
- Presentation of Tumor Antigens by Dendritic Cells Genetically Modified With Viral and Nonviral VectorsJournal of Immunotherapy, 2006
- Evaluation of Th1-like, Th2-like and immunomodulatory cytokine mRNA expression in the skin of dogs with immunomodulatory-responsive lymphocytic?plasmacytic pododermatitisVeterinary Dermatology, 2006
- A Single-Component CD40-Targeted Adenovirus Vector Displays Highly Efficient Transduction and Activation of Dendritic Cells in a Human Skin Substrate SystemMolecular Pharmaceutics, 2005
- Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninumVeterinary Immunology and Immunopathology, 2003
- Identification of Residues on CD40 and Its Ligand Which Are Critical for the Receptor-Ligand InteractionBiochemistry, 1995